The realization of long-term human organ preservation will have groundbreaking effects on the current practice of transplantation. Herein we present a new technique based on subzero nonfreezing preservation and extracorporeal machine perfusion that allows transplantation of rat livers preserved for up to four days, thereby tripling the viable preservation duration.
With over 120,000 patients waiting to receive a donor organ in the United States today 1 , the field of transplantation is facing a serious donor shortage crisis. Optimizing organ preservation to improve transplantation outcome has the potential to increase the availability of organs. The introduction of the University of Wisconsin (UW) solution by Belzer and Southard in the late 1980s (ref. 2) represented a pivotal breakthrough in hypothermic preservation (HP) of solid organs. It substantially extended the viable preservation time 3 , which led to the first intercontinental kidney transplant and provided a major thrust that led to the current success of organ transplantation. To this day, donor livers are preserved in ice-cold UW solution, which offers viable preservation up to 12 h. Extension of this storage time to a hypothetical 24 h would allow larger geographic organ-sharing regions, reduce pressure on procedural logistics and optimize recipient preparation. Together, such advances could contribute toward worldwide liver sharing with better outcomes, which would greatly reduce the donor shortage 4 .
Cryopreservation has been successful in numerous cell types and some simple tissues 5 ; however, its success for long-term storage of vascularized solid organs remains elusive owing to the adverse effects of extreme temperatures and the injurious processes necessary to reach them 6, 7 . Experimental endeavors to achieve viable long-term preservation of whole organs at subzero temperatures range from organ freezing and vitrification as low as −196 °C (refs. 4,8,9) to supercooling (subzero nonfreezing) at 0 °C to −5 °C (refs. [10] [11] [12] [13] [14] [15] [16] but have yet to yield long-term survival after transplantation. Challenges in subzero preservation of liver tissue are attributable to the delicate hepatic anatomy comprising multiple cell types with variable preservation properties and functions; for instance, frozen rat livers have been transplanted with apparently healthy hepatocytes and a functioning biliary system but ultimately failed owing to endothelial cell detachment and microvascular dysfunction 17 . Machine perfusion, which provides organ support through an extracorporeal artificial circulation, is an alternative technique that has been shown to be advantageous over conventional hypothermic storage and has since been implemented into routine clinical practice for kidney preservation 18, 19 . Although this method could hypothetically extend viable preservation times, its use for long-term preservation is impractical, and most studies focus on short-term preservation or recovery of warm ischemic or otherwise injured organs that would normally have been discarded [19] [20] [21] .
In this report we present a method for extended liver storage that combines supercooling and machine perfusion. Because HP primarily works through deceleration of cellular metabolism at lowered temperatures, our central hypothesis was that supercooling would enable further metabolic reduction and extension of the viable preservation time. However, supercooling poses several challenges: (i) ice formation can occur during subzero storage and needs to be avoided; (ii) extended storage at low temperatures, along with the rewarming process, can result in irreversible plasma membrane injuries 22, 23 and the eventual osmotic stress that follows; and (iii) cold temperatures and subsequent rewarming increase the susceptibility of cells to oxidative damage 24 . This particularly affects the hepatic sinusoid, which is the functional unit of the liver that directly interacts with the exterior milieu 25 . The sinusoidal endothelial cells are extremely sensitive to hypothermic injury, which leads to detrimental microcirculatory dysfunction 26, 27 . We developed a protocol and preservation solutions that address these issues and aim to dramatically extend liver preservation duration, as described below.
For HP, the UW preservation solution has been a success 28 . For the purposes of supercooling, we sought to supplement the solution to reduce cold-induced membrane injury and prevent freezing. As traditional cryoprotectants such as dimethyl sulfoxide and 2,3-butanediol are toxic and may lead to issues in clinical translation, we avoided their use and employed 35-kDa polyethylene glycol (PEG), which has been shown to protect the epithelial cell membrane 29, 30 and has been previously used as a colloid for liver machine perfusion, as well 31 .
Because PEG does not cross the cell membrane and is limited to extracellular medium, we also employed a cryoprotective additive to preserve the intracellular compartment. Inspired by freeze-tolerant species that produce high concentrations of glucose as a cryoprotectant 32 , we Supercooling enables long-term transplantation survival following 4 days of liver preservation
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tested a nonmetabolizable glucose derivative (3-O-methyl-d-glucose, 3-OMG) for supercooling preservation. 3-OMG is taken up naturally by hepatocytes through glucose transporters GLUT-1 and GLUT-2 and accumulates internally. 3-OMG is nontoxic and has already been employed clinically in glucose uptake studies 33 . Our group has previously shown that primary hepatocytes in vitro show superior post-thaw quality when cryopreserved with 3-OMG 34 .
To our knowledge, the study presented here is the first that has tested 3-OMG for supercooling.
Finally, to counter the effects of extended ischemia, we employed machine perfusion, which has been demonstrated to alleviate hypothermic endothelial injury, reinitialize metabolic activity, replenish ATP and mechanically prime the vasculature for reperfusion 19, [35] [36] [37] . We chose subnormothermic machine perfusion (SNMP) at 21 °C on the basis of our experience using SNMP to recover injured rat and, recently, human livers [38] [39] [40] .
The method, as displayed in Figure 1a , entails storage of rat livers for 3 or 4 d at −6 °C, more than thrice the maximum preservation time achievable by HP, validated by orthotopic transplantation. The protocol (comprehensive details are available in Online Methods) includes the following steps. Prior to supercooling, we used SNMP with modified Williams' E medium to load isolated rat livers with 0.2 M 3-OMG. We derived the dosage and loading characteristics of 3-OMG from in vitro experiments using isolated rat hepatocytes 34 . Next, we cooled the organ during SNMP to 4 °C (1 °C min -1 ) and flushed it with 10 ml 4 °C UW solution containing 5% 35-kDa PEG (UW-PEG). We submerged the liver in 75 ml of 4 °C UW-PEG. We then placed the liver inside a controlled-rate freezer and lowered the temperature further to −6 °C (0.1 °C min -1 ), initiating the supercooling phase that was maintained for 72 h (n = 6) or 96 h (n = 12). Following supercooling, we gradually increased the temperature to 4 °C. We then flushed the liver with room-temperature oxygenated Williams' E medium and subjected it to SNMP (3 h, 21 °C) while we recorded multiple viability parameters. We finally transplanted the liver orthotopically into healthy syngeneic rats. We obtained blood samples for up to 1 month and monitored the recipients for survival and clinical signs of cirrhosis for up to 3 months.
RESULTS

Post-transplantation
Three-month recipient survival in the group that received livers supercooled for 72 h was 100%, whereas animals receiving livers exposed to an equal duration of HP died from hepatic failure within the first 2 d ( Fig. 1b and Table 1 ). This result triples the achievable storage duration by HP, which is limited to 24 h in rat transplants. Increasing the duration of supercooling to 96 h resulted in 58% survival, which is comparable to the 50% survival achieved following 48 h of HP. Negative controls that received livers for which the SNMP loading phase or 3-OMG or PEG supplementation were individually omitted did not survive past day 6 ( Table 1) , whereas negative controls that received livers for which the SNMP recovery phase was omitted succumbed within 1 h after transplantation. Despite a prolonged postsurgical recovery period and increased postoperative cellular damage parameters (Fig. 1c) , recipients of livers from the 72-h and 96-h supercooling groups thrived for 3 months after transplantation without any signs of organ failure. Postoperative blood levels of albumin, bilirubin, alkaline phosphatase and blood urea normalized within 1 month after surgery, and coagulation times were normal in all animals (data not shown). There were no signs (either histological, and 72-h SC (n = 6) groups compared to fresh liver recipients (n = 6) (shown are all recipients, including those that did not survive past day 1). . Although supercooled livers produced less bile than fresh livers during SNMP recovery ( Fig. 2a) , their bile production was substantial compared to that of livers that underwent an equal duration of HP, in which bile production was minimal. Additionally, within the 96-h supercooling group, we observed a significant difference in bile production between livers that went to recipients that survived 30 d after transplantation and those that did not (P = 0.0017, Fig. 2a ). Increased hepatic resistance during SNMP recovery also correlated strongly with transplant survival in the 96-h supercooling group (P < 0.0001, Fig. 2b ), suggesting that both bile production and a mean resistance <15 cm H 2 O min ml −1 during SNMP recovery could be predictive of liver viability. Aminotransferase output during SNMP recovery was higher than that from fresh livers in both the 72-h and 96-h supercooling groups (Fig. 2c) . Within the 96-h supercooling group, we observed a significantly higher oxygen uptake in livers that went to surviving rats than in those that went to nonsurvivors (P < 0.0001; Fig. 2d ). Liver weight did not increase significantly in all supercooled livers (2.6 ± 1.7% increase, mean ± s.e.m., P > 0.05) or during recovery SNMP (5.6 ± 2.7% increase, P > 0.05), and there were no significant differences between groups (data not shown). H&E staining and transmission electron microscopy of livers after supercooling showed normal hepatic structure in all cases ( Fig. 2e) .
Post-supercooling samples contained intracellular accumulation of glycogen-like intracellular matter (enlarged in Fig. 2e) , which may be internalized 3-OMG. In the post-transplantation specimens, we observed hepatocyte crowding and biliary hyperplasia, consistent with typical hepatocellular regeneration after rat liver transplantation.
DISCUSSION
To our knowledge, supercooling is the first preservation technique capable of rendering livers transplantable after 4 d of storage. The protocol comprises four essential components: supercooling to −6 °C, 3-OMG and 35-kDa PEG as cryoprotectants and machine perfusion for the loading of 3-OMG as well as for recovery of hepatic viability and energy stores after supercooling, before transplantation. We have shown that each of these components is individually required to achieve viable supercooling preservation in our model, as evidenced by long-term recipient survival. We show here that 100% survival is limited to 72 h of storage, as the survival drops considerably, to 58%, when the storage time is extended to 96 h. As extensive screening of different additives or variations in protocol is still ongoing, additional improvements could be achieved from future experimentation. In addition, continued investigation of the individual protocol components should provide a better understanding of the mechanisms at play.
During SNMP recovery of the 96-h supercooling group, we retrospectively observed segregation of survivor and nonsurvivor recipients in terms of hepatic resistance after just 30 min of SNMP. Hence, the elevated hepatic resistance observed during the post-supercooling SNMP recovery can be interpreted as a marker for injury, which is similar to observations in nonsupercooling SNMP studies 40 .
As a proof-of-concept small-animal study, this model has limitations and requires validation in a large-animal model. The size, robustness and preservation properties of human hepatocytes and livers differ from those of rodents, presenting translational challenges not only regarding preservation biology, but also engineering and cost. For example, this model is not suited to investigate ischemic cholangiopathy, which does not occur in rat models of liver transplantation. Therefore, although our work here did not reveal any indication of cholangiopathy in our supercooled rat livers, this must be examined further using a higher-order species model that utilizes Fresh 72 npg clinically relevant biliary anastomosis and includes reconstruction of the hepatic artery. A second size-related issue is that in a human liver, the amount of liquid volume subject to freezing will be much larger and therefore the probability of freezing may increase; this may require additional modifications to the preservation solutions or supercooling protocol.
To establish the feasibility of our method, we used fresh livers, and we demonstrated substantially preserved viability and extension of preservation time. A next major use for a superior preservation protocol would be enhancing the preservation and utilization of marginal donor organs, such as ischemically injured livers donated after cardiac death. A next step will be to test and optimize the protocol described here to better preserve marginal livers and enable transplantation of currently untransplantable grafts.
The achievement of long-term survival after supercooling preservation, with more than a threefold increase in the currently achievable preservation time, signifies the potential of this preservation modality. The eventual goal of extending the viable preservation time of human organs will contribute toward global organ sharing and increased organ availability.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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